Mutagen-induced fetal anomalies and death following treatment of females within hours after mating.
In an earlier study (Generoso et al., 1987), it was observed that the mutagen, ethylene oxide (EtO), produced remarkable increases in the incidence of developmental abnormalities and death of fetuses when early zygotic stages were exposed. This is a major finding in experimental induction of embryopathy, implicating genetic damage to the zygotes as the likely cause. In the subsequent study reported here, 3 other mutagens--ethyl methanesulfonate (EMS), ethyl nitrosourea (ENU), and triethylene melamine (TEM), were studied for embryopathic effects following exposure of dictyate oocytes, prefertilization oviducal eggs and sperm, early pronuclear zygotes, zygotes undergoing pronuclear DNA synthesis, and two-cell embryos. All 4 mutagens produced developmental abnormalities among living fetuses following exposure of early pronuclear zygotes (the only stage studied for this endpoint in this report). With respect to stage specificity and gestational timing of death of conceptuses, EMS and EtO on one hand and ENU and TEM on the other, are very similar to one another. EMS, like EtO, produced a high incidence of midgestation and late fetal deaths only in prefertilization oviducal eggs and sperm and in early pronuclear eggs. In contrast, ENU and TEM produced high losses of conceptuses in all postmating stages studied but death occurred primarily prior to or around the time of implantation. Thus, the frequency of induction and the expression of embryopathy, which ranged from early embryonic preimplantation and late fetal deaths to subtle fetal anomalies, are dependent upon the stage exposed and the mutagen used.
Generoso
W M
WM
Biology Division, Oak Ridge National Laboratory, TN 37831.
Rutledge
J C
JC
Cain
K T
KT
Hughes
L A
LA
Downing
D J
DJ
D000014:Abnormalities, Drug-Induced / Q000196:embryology*; D000818:Animals; D002970:Cleavage Stage, Ovum / Q000187:drug effects*; D010064:Embryo Implantation / Q000187:drug effects; D005020:Ethyl Methanesulfonate / Q000633:toxicity; D005027:Ethylene Oxide / Q000633:toxicity; D005038:Ethylnitrosourea / Q000633:toxicity; D005260:Female; D005313:Fetal Death / Q000139:chemically induced*; D051379:Mice; D009153:Mutagens / Q000633:toxicity*; D009865:Oocytes / Q000187:drug effects*; D010063:Ovum / Q000187:drug effects*; D011247:Pregnancy; D014265:Triethylenemelamine / Q000633:toxicity; D015053:Zygote / Q000187:drug effects*
D009153:Mutagens; D005020:Ethyl Methanesulfonate; D014265:Triethylenemelamine; D005027:Ethylene Oxide; D005038:Ethylnitrosourea